SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

Investors are actively debating the legitimacy of various crypto tokens attempting to capitalize on the highly anticipated, multi-trillion dollar SpaceX IPO. While some participants are seeking exposure through the tokenized assets, others are warning of a potential scam, urging caution against the speculative hype surrounding Elon Musk's companies.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

The 4CHAN token is trending as community members position it as the "source code" of internet meme culture, aggressively promoting its potential for explosive growth based on its scarcity and symbolic value. While some critics view it as a high-risk speculative play, proponents are actively buying dips and emphasizing its community-driven, renounced contract as a stable hedge against broader market volatility.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is experiencing significant volatility and downward pressure as investors navigate sector-wide weakness and frustration over the stock's inability to maintain gains despite steady contract wins. While the community is actively debating whether the stock has bottomed or needs more time to heal, many remain bullish on the long-term outlook, highlighting strong fundamental backlog and the company's role in government, nuclear, and space infrastructure as key reasons to maintain their positions.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Papa John's is trending as investors weigh persistent takeover rumors, with reports suggesting that major franchisees and investment firms like Irth Capital are aggressively pushing for a deal to take the company private. While community sentiment remains split between those betting on a profitable buyout premium and those frustrated by management's past rejection of offers, the upcoming earnings call and shareholder meetings are being closely watched as potential catalysts for a definitive resolution.

4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.

4D Molecular Therapeutics Inc

4D Molecular Therapeutics is attracting significant attention as investors react to positive Phase 2 SPECTRA trial data for 4D-150 in diabetic macular edema, sparking discussions about its potential as a best-in-class, durable gene therapy. While the community is actively debating the company's valuation relative to its cash position and the timeline for upcoming pivotal data, momentum traders are closely monitoring price action and short interest as the company prepares for upcoming investor conferences.

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

ANI Pharmaceuticals Inc

ANI Pharmaceuticals is experiencing positive momentum driven by strong demand for its rare disease franchise, particularly Cortrophin Gel, and a robust pipeline of new product launches. The community is actively discussing the company's improved financial guidance and strategic efforts to scale its rare disease portfolio, while some remain cautious about broader sector headwinds and historical share price performance.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

Casey's General Stores is seeing significant investor attention driven by strong performance in its food and beverage segments, which are proving to be major traffic drivers alongside its core fuel business. The community is actively discussing its recession-proof business model and potential for further market expansion, keeping the stock a popular pick for those seeking quality and stability in a volatile environment.

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care is trending as investors monitor the company's progress with its DefenCath infection-prevention initiative, which the community highlights for its potential to improve patient outcomes and drive operating efficiency. Discussions are heavily focused on the company's role as a major player in the dialysis sector and how its operational strategies, including potential acquisitions and cost-saving measures, may influence its long-term market position.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is trending as investors scrutinize the company's $125 million acquisition by Garda Therapeutics at $18 per share, which many long-term shareholders feel significantly undervalues the core Rolvedon asset and follows a series of questionable portfolio divestitures. The community remains highly vocal about potential fiduciary failures, expressing intense frustration over management's decision-making and demanding accountability while waiting for the Schedule 14D-9 to clarify the valuation process.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is generating significant interest as investors weigh its tech-heavy exposure and monthly dividend yield against market volatility, with the community actively debating whether to hold the fund for consistent income or rotate into higher-yielding alternatives. Traders are closely monitoring a psychological price barrier near $60, viewing the recent market fluctuations as a potential entry point for long-term positions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Advisers are reportedly exploring broader international retail participation, including potential allocation partnerships with brokerage platforms in the U.K., Japan and Canada.</li><li>DXYZ has become a major retail proxy for SpaceX, with the company representing 16.2% of its portfolio.</li><li>The SpaceX IPO filing could coincide with the company’s upcoming Starship test flight.</li></ul>Shares of Destiny Tech100 (DXYZ), Tema Space Innovators ETF (NASA) and ERShares Private-Public Crossover ETF (XOVR) jumped overnight heading into Friday as investors rushed to gain indirect exposure to SpaceX ahead of the company’s expected IPO filing next week and a potentially record-shattering public offering.In overnight trading,&nbsp;<a href="https://stocktwits.com/symbol/DXYZ">DXYZ</a> gained 5%,&nbsp;<a href="https://stocktwits.com/symbol/NASA">NASA</a> rose 3%, while&nbsp;<a href="https://stocktwits.com/symbol/XOVR">XOVR</a> added 1%.&nbsp;<h2 class="st-heading-2">SpaceX IPO Filing Nears</h2>The rally comes as anticipation intensifies around Elon Musk’s reusable-rocket giant, which is reportedly expected to publicly release its IPO prospectus as soon as next week, ahead of a June 8 roadshow, CNBC&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2026/05/14/spacex-ipo-prospectus-could-land-as-soon-as-next-week-sources-say.html?taid=6a06331d76997b0001c3efff&amp;utm_campaign=trueanthem&amp;utm_content=main&amp;utm_medium=social&amp;utm_source=twitter">reported</a>, citing sources familiar with the matter.SpaceX confidentially filed for an IPO in April and is expected to pursue one of the largest listings ever attempted on Wall Street. The company is reportedly targeting a $70 billion to $75 billion raise and aiming for a valuation above $1.75 trillion, a scale that would more than double Saudi Aramco’s record $29 billion IPO in 2019, the largest public offering ever.&nbsp;SpaceX’s advisers are reportedly considering international retail participation given the size of the offering, including potential allocation partnerships with brokerage platforms in markets such as the U.K., Japan and Canada. The filing could also be released slightly ahead of schedule to give investors more time to evaluate the company’s financials before the June roadshow begins.&nbsp;The IPO follows SpaceX’s merger with Musk’s AI company xAI in February, valuing the combined firm at $1.25 trillion. Investor enthusiasm around SpaceX has accelerated as the company expands far beyond its core rocket launch business into satellite broadband, AI infrastructure, direct-to-cell communications and orbital data systems.Recently, Musk said xAI would no longer operate as a separate company and would instead integrate directly into SpaceX under the “SpaceXAI” banner, further boosting the company’s position amid the broader AI investment boom. The expected filing could also coincide with SpaceX’s upcoming Starship test flight, adding another major catalyst ahead of the IPO.&nbsp;<h2 class="st-heading-2">DXYZ Emerges As Leading SpaceX Proxy</h2>DXYZ has become one of the market’s most closely watched retail vehicles for indirect exposure to SpaceX. SpaceX currently represents the largest holding within Destiny Tech100’s portfolio at 16.2% of total assets. The closed-end investment company also provides investors with exposure to several other high-profile private technology firms, including xAI, OpenAI, Anthropic, Databricks and Shield AI.The structure has attracted retail investors looking for access to late-stage private technology companies before they enter public markets. As of Dec. 31, 2025, Destiny Tech100 reported a net asset value of $19.97 per share, up 76% from the prior quarter and more than 210% from a year earlier. Total portfolio fair value rose to $434 million.The fund later expanded its portfolio through investments tied to Anthropic, Chaos Industries and aerospace company Hermeus Corporation.<h2 class="st-heading-2">XOVR, NASA Offer Alternative SpaceX Exposure</h2>Investors also rotated into XOVR, which combines public equities with exposure to selected private firms. As of Dec. 31, the ETF managed $1.49 billion in assets. SpaceX accounted for 10.86% of the portfolio through special-purpose vehicle exposure, making it one of the fund’s largest positions alongside Nvidia, Meta, Instacart and Affirm Holdings. The ETF structure allows investors to maintain daily liquidity while still accessing private-market exposure typically unavailable through traditional exchange-traded funds.NASA ETF also drew investor attention as the fund maintains a 10% exposure to SpaceX through a special-purpose vehicle structure and also holds positions in space and satellite-related companies, including AST SpaceMobile, Rocket Lab, Planet Labs and Intuitive Machines.The portfolio is broadly focused on launch infrastructure, satellite connectivity, orbital defense systems and commercial space technologies. Tema ETF chief investment officer Yuri Khodjamirian previously called SpaceX “the defining company of the space economy.”<h2 class="st-heading-2">How Do Retail Traders Feel About DXYZ, NASA And XOVR?</h2>On Stocktwits, retail sentiment around DXYZ and NASA was ‘extremely bullish’ amid ‘extremely high’ message volume, while sentiment on XOVR was ‘bullish’ with ‘normal’ message volume.One user&nbsp;<a href="https://stocktwits.com/LittleIronman2/message/653453412">said</a>, “SpaceX going to be releasing steady amounts of news to and after IPO. It’ll be over $2T. The new frontier with stable earth revenue.”<stembedurl>https://stocktwits.com/LittleIronman2/message/653453412</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/ride_the_volatality/message/653438552">said</a>, “Next week it is guys, SpaceX will file prospectus and this will see a lot of retail interest immediately.”<stembedurl>https://stocktwits.com/ride_the_volatality/message/653438552</stembedurl>Over the past year, DXYZ has gained 7%, NASA has climbed 43%, while XOVR is up 6%.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sls-stock-conference-season-investors-aml-readout-hints/cZXlLCvReSN">SLS Stock Surges Into Conference Season As Investors Hunt For AML Readout Hints&nbsp;</a>

A SpaceX Falcon 9 rocket lifts off from launch pad 40 at the Cape Canaveral Space Force Base carrying a classified satellite for the NRO (National Reconnaissance Office). 

DXYZ, NASA, XOVR Rise Overnight: Investors Rush For SpaceX Exposure Ahead Of Next Week’s IPO Filing

SpaceX is reportedly preparing to launch its IPO roadshow on June 8.

Equity

<ul class="summary-bullets"><li>SpaceX IPO excitement and Anthropic’s $1.4 trillion implied valuation have fueled investor demand for VCX exposure.</li><li>Anthropic represents about 21% of VCX’s portfolio, alongside holdings in OpenAI, Databricks, Anduril, Ramp and SpaceX.</li><li>Vervia Partners’ Anthony Showalter warned that VCX is trading far above the underlying value of its holdings.</li></ul>Shares of Fundrise Innovation Fund (VCX) have turned into one of Wall Street’s hottest AI trades as retail investors rush for indirect exposure to Anthropic, SpaceX and OpenAI ahead of potential blockbuster IPOs. However, one investor now warns that the stock could still face a brutal reality check.Since their respective launches,&nbsp;<a href="https://stocktwits.com/symbol/VCX">VCX</a> has surged 2,172%, significantly outperforming rival and private-tech exposure funds, including&nbsp;<a href="https://stocktwits.com/symbol/DXYZ">Destiny Tech100 (DXYZ)</a>, up 692%,&nbsp;<a href="https://stocktwits.com/symbol/XOVR">ERShares Private-Public Crossover ETF (XOVR)</a>, up 121%, and&nbsp;<a href="https://stocktwits.com/symbol/NASA">Tema Space Innovators ETF (NASA)</a>, up 35%.<img src="https://news.stocktwits-cdn.com/koyfin_20260511_114518469_png_fa4873ee09.webp" alt="koyfin_20260511_114518469.png">VCX is a closed-end fund that debuted on the NYSE in March and immediately became one of the market’s most explosive retail trades. Within days of listing, VCX surged more than 1,500% above its reported net asset value (NAV). At one point, shares traded at over 16x the fund’s reported NAV of $18.97 per share as repeated volatility halts hit the stock.<h2 class="st-heading-2">VCX Rides SpaceX And Anthropic Hype</h2>Much of the excitement for VCX comes from surging retail interest in both SpaceX and Anthropic. SpaceX has evolved beyond a launch company into a sprawling AI, satellite broadband and infrastructure platform spanning Starlink, direct-to-cell connectivity, hyperscale processing ambitions and potential orbital data centers.Investors have also focused heavily on the possibility of a historic SpaceX IPO that could value the company at nearly $2 trillion and trigger massive passive&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/spacex-ipo-etf-demand-vanguard-qqq-tesla-influencer/cZQMjCvRe7r">ETF inflows</a> due to accelerated index inclusion rule changes across Nasdaq, S&amp;P and FTSE Russell.Meanwhile, Anthropic’s implied pre-IPO valuation has surged to $1.4 trillion, climbing about 40% in just 24 days as private-market demand for the Claude developer intensified ahead of a potential public listing later this year. The AI company’s implied valuation is now up more than 1,000% since October 2025, fueled largely by enterprise adoption of Claude and Claude Code. Annualized revenue estimates have climbed from $100 million in 2023 to $45 billion currently, according to&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/KobeissiLetter/status/2053896786142789725">The Kobeissi Letter</a>.Anthropic has emerged as one of the industry’s largest AI infrastructure spenders, signing major deals with Amazon Web Services, Alphabet, CoreWeave and SpaceX. Last week, Anthropic deepened ties with SpaceX by securing access to more than 300 megawatts of processing capacity from SpaceX’s Colossus 1 facility in Memphis, Tennessee.<h2 class="st-heading-2">VCX: Retail’s Gateway To Private AI</h2>The excitement for IPOs has increasingly spilled into VCX since Anthropic alone accounts for 21% of its portfolio, while OpenAI, Databricks, Anduril, Ramp and SpaceX make up other major positions.Fundrise CEO Ben Miller has previously said that VCX gives ordinary investors access to elite private-market opportunities traditionally reserved for institutions and venture capital firms. “Let the retail investors be the ones who get the inside shares rather than the hedge funds,” Miller&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/vcx-tumbles-premarket-fundrise-opens-space-x-anthropic-databricks-onchain-after-snubbing-hedge-funds/cZERjq7RIZl">said in March</a>.Since VCX’s July 2022 inception, cumulative returns total 84%, meaning a $10,000 investment would have grown to about $19,256, including $9,030 in appreciation and $225 in distributions, according to Fundrise data.&nbsp;<h2 class="st-heading-2">Investor Questions VCX’s Massive Premium</h2>However, not everyone believes VCX’s massive rally is sustainable. Anthony Showalter, managing partner at Vervia Partners, said investors are confusing exposure to elite private companies with reasonable valuation. “This is not an anti-AI short. It is not even an anti-Fundrise short. It is a wrapper-math short,” Showalter&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/santhonys/status/2053604997745815742">said on X</a> in a detailed report published on Monday.The investor acknowledged the strength of VCX’s underlying portfolio, calling companies like Anthropic, OpenAI and SpaceX “extraordinary companies,” but said the premium investors are paying through VCX has detached from economic reality. “The mistake investors are making is confusing exposure with value,” Showalter said. “VCX gives you exposure to extraordinary companies. It does not follow that any price for that exposure makes sense.”Showalter said that many traders are treating VCX like a traditional ETF, in which rising demand automatically increases ownership of the underlying holdings. According to him, VCX owns a relatively fixed number of shares in companies such as Anthropic, Databricks, Ramp and SpaceX, meaning that the fund cannot simply manufacture more exposure as demand rises.<h2 class="st-heading-2">Even VCX’s ‘Dream Scenario’ Looks Overvalued&nbsp;</h2>Using secondary-market pricing for Anthropic, SpaceX, OpenAI and other holdings, Showalter estimated that VCX still trades at a massive premium even under extremely bullish assumptions. In his “Aggressive Marks” scenario, Anthropic was valued at $1.3 trillion and VCX still produced an estimated NAV of only about $46 per share compared with a market price near $191. Under an even more bullish “Dream Scenario,” where major holdings doubled again from already elevated levels, Showalter estimated NAV at $76.55 per share.“To put that another way: even if you are the most aggressive Anthropic bull alive, even if you believe Sacks is right and Anthropic becomes the most valuable company in human history, even if SpaceX and OpenAI both 6x from where they sit today, VCX still has to lose roughly half its value to reach the underlying marked NAV,” Showalter said.Showalter also warned that ongoing share issuance could dilute investors’ exposure to key holdings over time, since Fundrise cannot acquire shares of Anthropic or SpaceX quickly enough to keep pace with the inflow of new money into the fund. “A great asset can still be a terrible security if the wrapper is priced absurdly,” he said.<h2 class="st-heading-2">How Do Retail Traders Feel About VCX?</h2>On Stocktwits, retail sentiment for VCX has jumped to ‘extremely bullish’ from ‘bullish’ levels over the past week amid a 1,540% surge in 24-hour message volumes. Over the past month, the stock’s retail-watcher base has also risen by nearly 40%.<figure class="image"><img src="https://news.stocktwits-cdn.com/vcx_ss_png_09861740c3.webp" alt="vcx ss.png" width="973" height="142"><figcaption>VCX sentiment and message volume as of May 12 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/theMeans/message/653029554">said</a>, “If you believe AI is the future, then there is no other portfolio that dominates the market like<a href="https://stocktwits.com/symbol/VCX"> $VCX</a> … none. you're betting on the entire ecosystem: the models (Anthropic/OpenAI), the data (Databricks), and the physical application (Anduril/SpaceX). Even if one fails, the others are positioned to dominate.”<stembedurl>https://stocktwits.com/theMeans/message/653029554</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/LiquidityTaker/message/652989987">said</a>, “$VCX is absolutely ripping through levels and I’m just watching the tape in disbelief. Up +1,913% and still printing higher highs like it doesn’t care about gravity.”<stembedurl>https://stocktwits.com/LiquidityTaker/message/652989987</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/asts-stock-tanks-analyst-warns-launch-delays-after-pumping/cZXQvHeReLR">ASTS Stock Tanks Overnight After Q1 Miss: Analyst Says Recent ‘Pumping’ Came Ahead Of Major Launch Delays&nbsp;</a>

In this photo illustration, a smartphone displays the logo of artificial intelligence company Anthropic in front of a SpaceX logo background on May 7, 2026, in Shenzhen, Guangdong Province, China. (Photo illustration by Cheng Xin/Getty Images)

VCX Heading For 50% Crash? Investor Explains ‘Wrapper-Math Short’ Logic Even In Most Bullish AI Case

Since their respective launches, VCX has surged 2,172%, outperforming rival and private-tech exposure funds including DXYZ, XOVR and NASA.

VCX Becomes Retail’s AI Darling On SpaceX, Anthropic Hype — One Investor Warns Of 50% Crash 

The SpaceX logo appears on a smartphone screen placed on a laptop keyboard illuminated by blue light. (Photo by Samuel Boivin/NurPhoto via Getty Images)

SpaceX Starlink Glitch Strikes In Space – Zero Risk To Moon Mission

Starlink said that it will continue to monitor the satellite and coordinate with NASA and the U.S. Space Force following the incident.

XOVR ETF Offers Pre-IPO SpaceX Exposure

XOVR ETF Offers Pre-IPO SpaceX Exposure XOVR ETF Offers Pre-IPO SpaceX Exposure PR Newswire NEW YORK, March 30, 2026 With SpaceX reportedly evaluating a confidential IPO at a valuation approaching...

In this photo illustration, the logo of SpaceX is displayed on a smartphone screen.

Want In On SpaceX Before The IPO? Here Are 5 Funds That Already Own It

Investors are increasingly turning to a handful of listed funds that already hold stakes in SpaceX as one of the few ways to gain exposure before the company begins trading publicly.

Zacks Investment Ideas feature highlights: Tesla, RONB, BPTRX, BFGFX, and XOVR

Tesla, RONB, BPTRX, BFGFX, and XOVR have been highlighted in this Investment Ideas article.


Want SpaceX Before the IPO? These Funds Are All In

We highlight funds that provide exposure to SpaceX as it prepares for a historic IPO.

ERShares' XOVR ETF Opens the Door to Pre-IPO Stage Investing

ERShares' XOVR ETF Opens the Door to Pre-IPO Stage Investing ERShares' XOVR ETF Opens the Door to Pre-IPO Stage Investing PR Newswire NEW YORK, Oct. 14, 2025 NEW YORK, Oct. 14, 2025 /PRNewswire...

From SpaceX to xAI: How ETFs Are Packaging Private Assets

ETFs are opening doors to private markets: here's what investors need to know

XOVR
Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest XOVR News

XOVREntrepreneurshares Series Trust - ERShares Private-Public Crossover ETF